Document is current
Any future updates will be listed below
-
Authors
Pardo, Emmanuel
Lescot, Thomas
Preiser, Jean-Charles
Massanet, Pablo
Pons, Antoine
Jaber, Samir
Fraipont, Vincent
Levesque, Eric
Ichai, Carole
Petit, Laurent
Tamion, Fabienne
Taverny, Garry
Boizeau, Priscilla
Alberti, Corinne
Constantin, Jean-Michel
Bonnet, Marie-Pierre
,
Samba, Désiré
Moyer, Jean-Denis
Montravers, Philippe
Mongardon, Nicolas
Meffert, Arnaud
De Jong, Audrey
Belafia, Fouad
Morel, Jérome
Asehnoune, Karim
Mahé, Pierre-Joachim
D’Hondt, Alain
Paquot, Nicolas
Leone, Marc
Kaidomar, Michel
Grech, Ludovic
Gouteix, Eliane
Barsam, Elise
Duranteau, Jacques
Martinez, Orianne
-
Funding
Funding for this research was provided by:
Baxter International
- License Information
-
More Information
Article History
Received: 9 November 2022
Accepted: 28 December 2022
First Online: 7 January 2023
Declarations
:
: The study was approved by the French Committee for the Protection of Human Subjects in Biomedical Research Paris Ile de France IV Saint-Louis (IRB00003835—July 24th 2014) and by the Belgium ethics committee of Erasme Universitary Hospital (P2015/083—May 13th 2015). The access to health information was approved by the French Data Protection Committee (Commission Nationale Informatique et Libertés—915109—DR-2015-304—July 17th 2015). According to French Law, informed consent was not required; a non-opposition statement was obtained after ad hoc information was given to all patients/relatives []. Participants' confidentiality was strictly observed throughout the study using the anonymous unique serial number for each subject and restricting data only to the investigators. This study was retrospectively registered on November 5th 2015 (ClinicalTrial.gov, NCT02599948).
: All authors read and approved the final manuscript before publication.E.P. received a research grant from Nestle Healthscience, teaching fees from Fresenius Kabi and congress reimbursement from Fresenius Kabi and Nutricia. T. L. received consultant’s fees from Fresenius Kabi.
